{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:05:35Z","timestamp":1759601135324},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.mrgentox.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T16:04:13Z","timestamp":1273680253000},"page":"111-117","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in cultured cord-blood lymphocytes of newborns of women treated for epilepsy during pregnancy"],"prefix":"10.1016","volume":"701","author":[{"given":"Monika","family":"Witczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Kociszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wilczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dobros\u0142awa","family":"\u0141opaczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Ferenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mrgentox.2005.05.006","article-title":"Micronucleus frequency in human umbilical cord lymphocytes","volume":"586","author":"Levario-Carillo","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3476(71)80025-2","article-title":"Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects","volume":"78","author":"Mirkin","year":"1971","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003081-200203000-00004","article-title":"Drug effects on the fetus and breast\u2013fed infant","volume":"45","author":"Briggs","year":"2002","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2165\/00003495-200767180-00007","article-title":"Management of epilepsy during pregnancy","volume":"67","author":"Battino","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0890-6238(91)90091-S","article-title":"Prenatal epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: human studies","volume":"5","author":"Dansky","year":"1991","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.1998.tb01186.x","article-title":"Pregnancies of women with epilepsy: a population-based study in Iceland","volume":"39","author":"Olafson","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00016347309158321","article-title":"The course and outcome of pregnancy in women with epilepsy","volume":"52","author":"Bjerkedul","year":"1973","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"Suppl. 3","key":"10.1016\/j.mrgentox.2010.05.003_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1528-1157.44.s3.3.x","article-title":"Pharmacology of neural tube defects","volume":"44","author":"Pippenger","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib9","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3949\/ccjm.71.Suppl_2.S25","article-title":"Risks and management of pregnancy in women with epilepsy","volume":"71","author":"Yerby","year":"2004","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.0013-9580.2004.458008.x","article-title":"Epilepsy and pregnancy","volume":"45","author":"Oguni","year":"2004","journal-title":"Epilepsy"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ncpneuro0153","article-title":"Therapy insight: clinical management of pregnant women with epilepsy","volume":"2","author":"Pack","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogeneticity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib13","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate","volume":"16","author":"Perucca","year":"2002","journal-title":"CSN Drugs"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib14","first-page":"265","article-title":"Medical genetics: 1. Clinical teratology in the age of genomics","volume":"167","author":"Polifka","year":"2002","journal-title":"CMJ"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib15","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00200.x","article-title":"Epilepsy and pregnancy: lamotrigine as main drug used","volume":"109","author":"Sabers","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.wco.0000162854.67767.06","article-title":"Teratogenicity of antiepileptic drugs: state of the art","volume":"18","author":"Tomson","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib19","first-page":"PH1","article-title":"Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Servis","volume":"14","author":"De Santis","year":"2008","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib20","first-page":"305","article-title":"Drug use in pregnancy","volume":"270","author":"Mc Elhatton","year":"2003","journal-title":"Pharm. J."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-8749.2007.02020.x","article-title":"Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development","volume":"50","author":"Titze","year":"2008","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","article-title":"Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of antiepileptic drugs in pregnancy","volume":"11","author":"Vajda","year":"2004","journal-title":"J. Clin. Neurosci."},{"issue":"Suppl. 3","key":"10.1016\/j.mrgentox.2010.05.003_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1528-1157.44.s3.5.x","article-title":"Pathobiology and genetics of neural tube defects","volume":"44","author":"Finnell","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(04)17445-X","article-title":"Spina bifida","volume":"364","author":"Mitchell","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1203\/PDR.0b013e3180a02e50","article-title":"Antiepileptic medication during pregnancy: does fetal genotype affect outcome?","volume":"62","author":"Atkinson","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0074-7742(08)00014-7","article-title":"Antiepileptic drug therapy II: fetal and neonatal exposure","volume":"83","author":"Hovinga","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/mol.105.017855","article-title":"Valproic acid increases conservative homologous recombination frequency and reactive oxygen species formation: a potential mechanism for valproic acid-induced neural tube defects","volume":"69","author":"Defoort","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tox.2005.10.004","article-title":"Valproic acid monotherapy induces DNA oxidative damage","volume":"217","author":"Schulpis","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and risk of birth defects","volume":"343","author":"Hern\u00e1ndez-D\u00edaz","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1528-1157.2001.44300.x","article-title":"Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality","volume":"42","author":"Duncan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib31","first-page":"285","article-title":"Mutagenic activity of diazepam evaluated by in vivo cytogentic test","volume":"29","author":"Garza","year":"1998","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-7992(90)90124-3","article-title":"The effect of valproic acid on SCE and chromosome aberrations in epileptic children","volume":"243","author":"Hu","year":"1990","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-1161(94)90029-9","article-title":"Sister-chromatid exchanges in epileptic patients on anticonvulsant therapy","volume":"313","author":"Sardas","year":"1994","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0165-1161(95)90019-5","article-title":"Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia","volume":"334","author":"Sinues","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-1218(87)90023-1","article-title":"The in vitro lymphocyte assay for assessing the clastogenicity of chemical agents","volume":"189","author":"Preston","year":"1987","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0014-4827(60)90138-5","article-title":"Chromosome preparations of leukocytes cultured from human peripheral blood","volume":"20","author":"Moorheead","year":"1960","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/251156a0","article-title":"New Giemsa method for the differential staining of sister chromatids","volume":"251","author":"Perry","year":"1974","journal-title":"Nature (London)"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-7992(92)90135-5","article-title":"Are mitotic index and lymphocyte proliferation kinetics reproducible endpoints in genetic toxicology testing?","volume":"282","author":"Rojas","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib39","unstructured":"ISCN 2005. An International System for Human Cytogenetics Nomenclature. Report of the standing committee on human cytogenetic nomenclature, in: Karger (ed.). S. Karger Publishers, Inc., Basel, Paris, London, 2005, pp. 59\u201387."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","article-title":"HUmanMicroNucleus project. HUMN project: detailed description of the scoring criteria for the cytokinesis-bloc micronucleus assay using isolated human lymphocyte cultures","volume":"534","author":"Fenech","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","article-title":"Cytokinesis-block micronucleus cytome assay","volume":"2","author":"Fenech","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1528-1157.1985.tb05661.x","article-title":"Effects of carbamazepine on human chromosomes","volume":"26","author":"Schaumann","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1520-6866(1999)19:1<61::AID-TCM7>3.0.CO;2-O","article-title":"Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysis","volume":"19","author":"Kaul","year":"1999","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1520-6866(2001)21:2<135::AID-TCM3>3.0.CO;2-7","article-title":"I. The modulatory effect in genotoxic responses due to age and duration of PHT-therapy in epileptic patients","volume":"21","author":"Kaul","year":"2001","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1990.tb05502.x","article-title":"Comparative effects of phenytoin and\/or phenobarbital treatment on sister chromatid exchange","volume":"31","author":"Schumann","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1528-1157.2003.58802.x","article-title":"Phenobarbital enhances sister chromatid exchanges in vivo","volume":"44","author":"Bellini","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1520-6866(1999)19:1<73::AID-TCM8>3.0.CO;2-E","article-title":"Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. II. Mitotic indeks (MI) and proliferation kinetics","volume":"19","author":"Kaul","year":"1999","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/01480540600566832","article-title":"The assessment of genotoxicity of carbamazepine using cytokinesis-block (CB) micronucleus assay in cultured human blood lymphocytes","volume":"29","author":"Celik","year":"2006","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1741-4520.2006.00104.x","article-title":"Etiology, pathogenesis and prevention of neural tube defects","volume":"46","author":"Padmanabahn","year":"2006","journal-title":"Congenit. Anom."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000098053","article-title":"The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children","volume":"57","author":"Aycicek","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jnutbio.2009.06.008","article-title":"DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging","volume":"20","author":"Kim","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1383-5742(99)00053-8","article-title":"The Human MicroNucleus Project\u2014an international collaborative study on the use of micronucleus technique for measuring DNA damage in humans","volume":"428","author":"Fenech","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib53","first-page":"59","article-title":"Fragile sites are target of diverse mutagens and carcinogens","volume":"1","author":"Yunis","year":"1987","journal-title":"Oncogene"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0027-5107(02)00086-6","article-title":"Micronuclei, nucleoplastic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytogenesis-block micronucleus assay","volume":"504","author":"Fenech","year":"2002","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib55","first-page":"3","article-title":"Human chromosome fragility","volume":"1779","author":"Lukusa","year":"2008","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.mrgentox.2010.05.003_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000072843","article-title":"Common fragile sites","volume":"100","author":"Arlt","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.canlet.2005.08.032","article-title":"Common fragile sites","volume":"232","author":"Glover","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib58","first-page":"293","article-title":"Chromosome fragile sites in mentally retarded males: increased incidence with seizure and diphenylhydantoin therapy","volume":"28","author":"Hodges","year":"1998","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.mrgentox.2010.05.003_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/pd.1134","article-title":"A fragile site at 10q23 (FRA 10A) in phenytoin-exposed fetus: a case report and review of the literature","volume":"25","author":"Morrel","year":"2005","journal-title":"Prenat. Diagn."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571810001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571810001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T06:51:35Z","timestamp":1544511095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571810001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1383571810001695"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2010.05.003","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}